Skip to content
Prof. Dr. Mustafa Özdoğan · Medical Oncologist

Active Surveillance Instead of Surgery for Low-Grade Ductal Carcinoma in Situ, a Type of Breast Cancer!

Active Surveillance Instead of Surgery for Low-Grade Ductal Carcinoma in Situ, a Type of Breast Cancer!

Ductal carcinoma in situ (DCIS) is the beginning of abnormal changes in the cells lining the breast milk ducts and is a very early stage of breast cancer. If a breast biopsy is reported as ductal carcinoma in situ, this means that some cells in your breast ducts have begun to turn into cancer cells. The main treatment for DCIS is surgery, in which the tumor is removed with some normal surrounding tissue. This breast cancer surgery is called "wide local excision" or "lumpectomy."

One of the notable studies at the latest ASCO meeting, where the most valuable cancer studies are presented, was a widely discussed study on this topic published in JAMA Surgery. According to this study, low-grade DCIS can be monitored without surgery.

This study compared surgery with annual mammographic surveillance for low-grade DCIS.

DCIS can be classified as high, intermediate, or low grade. High-grade tumors tend to multiply faster, recur more frequently after treatment, and are more likely to become conventional breast cancer (invasive ductal carcinoma).

Physicians' general approach to DCIS treatment is to recommend surgical removal when it is detected. In the current study, 57,222 patients with DCIS who underwent surgery or were monitored with annual mammography without surgery were followed for 10 years. The most important finding was that surgery provided no additional survival benefit for patients with low-grade tumors.

In conclusion, the findings of this study have the potential to change our clinical practice. Surgery for low-grade DCIS offers less benefit than for intermediate- and high-grade DCIS. However, prospective clinical trials are needed to examine the feasibility of active surveillance in low-grade DCIS treatment.

Sources

Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study. Yasuaki Sagara, MD; Melissa Anne Mallory, MD; Stephanie Wong, MD; Fatih Aydogan, MD; Stephen DeSantis, BS; William T. Barry, PhD; Mehra Golshan, MD. JAMA Surg. Published online June 03, 2015

https://archsurg.jamanetwork.com/article.aspx?articleid=2300045

Appointment request

DROZDOGAN AI

Explore this article together

Ask about the article and read answers alongside published sources from our site.

DROZDOGAN AI

Drozdogan Assistant

Active Surveillance Instead of Surgery for Low-Grade Ductal Carcinoma in Situ, a Type of Breast Cancer!

Ask about the article and read answers alongside published sources from our site.

Conversation and privacy information

Drozdogan Assistant answers this conversation. Authorized site administrators may review it for quality. Do not share personal information.

Replies use OpenAI infrastructure. Questions and replies are processed by that service; conversation records are stored on our site. Do not share identifying, contact or personal health information.

0 / 1000

For information only; no personal diagnosis or treatment advice.

Related articles

Explore other articles on this topic.

Stay informed

Receive new articles and scientific updates by email.

Google Analytics runs on public pages independently of this window and may use analytics cookies. Your choice here controls external services only.

Cookie policy